This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SunLink Health Systems, Inc. Announces Fiscal 2012 Third Quarter And Nine Month Results

Stocks in this article: SSY

SunLink Health Systems, Inc. (NYSE MKT: SSY) today announced a loss from continuing operations for its third fiscal quarter ended March 31, 2012 of $1,217,000, or a loss of $0.13 per fully diluted share, compared to a loss from continuing operations of $568,000, or a loss of $0.07 per fully diluted share for the quarter ended March 31, 2011. The results for the quarter ended March 31, 2012 include a pre-tax impairment charge of $931,000 to write down goodwill resulting from the October 2003 acquisition of two hospitals. For the nine month period ended March 31, 2012 the company reported a loss from continuing operations of $3,561,000, or a loss of $0.38 per fully diluted share, compared to a loss from continuing operations of $4,708,000, or $0.58 loss per fully diluted share, for the nine months ended March 31, 2011.

SunLink reported a net loss of $1,544,000, or a loss of $0.16 per fully diluted share for the quarter ended March 31, 2012, compared to a net loss of $314,000, or a loss of $0.04 per fully diluted share, for the comparable quarter a year ago. For the nine month period ended March 31, 2012 the company reported a net loss of $4,033,000, or a loss of $0.43 per fully diluted share, compared to a net loss of $4,848,000, or a loss of $0.60 per fully diluted share in the comparable period last year.

Consolidated net revenues from continuing operations for the quarters ended March 31, 2012 and 2011 were $39,484,000 and $42,376,000, respectively, a decrease of 6.8% in the current year’s quarter. The Healthcare Facilities Segment net revenues in the current quarter of $27,943,000 decreased $1,743,000 or 5.9%, compared to $29,686,000 from the prior year. Net revenues from state indigent care programs decreased $760,000 in the current year’s quarter compared to last year. The Specialty Pharmacy Segment revenues of $11,541,000 in the quarter ended March 31, 2012 decreased 9.1% from the prior year. Consolidated net revenues from continuing operations for the nine months ended March 31, 2012 decreased by 6.4% to $112,039,000 compared to $119,713,000 in the comparable period a year ago. The Healthcare Facilities Segment had net revenues in the nine months ended March 31, 2012 of $82,071,000 compared to $86,637,000 last year. The Specialty Pharmacy Segment had $29,968,000 of net revenue for the nine months ended March 31, 2012 compared to $33,076,000 in the comparable period a year ago.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs